21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology
21基因复发评分用于预后评估和预测辅助化疗联合内分泌治疗后紫杉烷类药物的疗效:来自NSABP B-28/NRG肿瘤学研究的结果
期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-017-4550-8
Mamounas, Eleftherios P; Tang, Gong; Paik, Soonmyung; Baehner, Frederick L; Liu, Qing; Jeong, Jong-Hyeon; Kim, S Rim; Butler, Steven M; Jamshidian, Farid; Cherbavaz, Diana B; Sing, Amy P; Shak, Steven; Julian, Thomas B; Lembersky, Barry C; Lawrence Wickerham, D; Costantino, Joseph P; Wolmark, Norman